Skip to main content
International Journal of Clinical and Experimental Pathology logoLink to International Journal of Clinical and Experimental Pathology
. 2019 Apr 1;12(4):1406–1411.

Giant recurrent mixed-type liposarcoma of the retroperitoneum: report of a case and review of literature

Cheng-Fang Li 1, Xiao-Rong Yang 1, Jin Yao 1, Jia-Jia Huang 1, Na Tan 1, Su-Yuan Zhang 1, Gao-Qiang Xu 2, Hong Zheng 1
PMCID: PMC6947073  PMID: 31933956

Abstract

Retroperitoneal liposarcoma is a rare tumor with an incidence of 2.5 per million individuals, especially tumors of mixed histologic pattern. We present a case of a 63-year-old woman with a history of slowly increasing abdominal volume over 2 years. The diagnosis of giant and multiple retroperitoneal mass suspected of liposarcoma was confirmed by computed tomography. The patient underwent resection of 7 tumor masses together weighing 5 kg. The microscopic diagnosis was mixed-type liposarcoma of the retroperitoneum. 8 months after surgery, the patient suffered multiple metastases in the liver and abdominal wall, and upper digestive tract hemorrhage. Although this type of tumor is rarely seen, tumor tissue should be thoroughly gathered and analyzed on histologic examination to reach final diagnosis. Knowledge of the subtype of liposarcoma is important for proper prognosis and treatment of the patient. To the best of our knowledge, this is the first report of mixed-type retroperitoneal liposarcoma with three components described in the English literature.

Keywords: Mixed-type liposarcoma, recurrence, metastases

Introduction

Liposarcomas (LPS), accounting for about 20% of all sarcomas in adults [1], consist of 4 distinct clinicopathologic entities by the World Health Organization: well-differentiated/dedifferentiated LPS (including adipocytic, sclerosing, inflammatory, and spindle cell variants); myxoid (and round cell) LPS, and pleomorphic LPS [2]. Occasionally, some or all of these components combine and they are then called mixed-type liposarcoma, which accounts for 4% of liposarcoma [3]. LPS occurs most commonly in the extremities (52%), followed by the retroperitoneum (19%) [4]. Retroperitoneal liposarcoma is usually symptomless until the liposarcoma is large enough to compress the surrounding organs [5]. It is often misdiagnosed due to its rarity and absence of symptom. Even with complete removal of the liposarcoma, prognosis remains poor. The 5-year survival rate of well-differentiated retroperitoneal liposarcoma is 83%, while it is 20% for the dedifferentiated tumor subtype [6]. According to our best knowledge, there are no literature reports on the prognosis of mixed type liposarcoma. Here, we present a uncommon case of mixed type liposarcoma composed of WDL, MLPS and DLPS, which developed in the retroperitoneum of a 63-year-old woman, followed by review of the literature.

Presentation

A 63 year-old female was admitted to the Department of Surgery, the Affiliated Hospital, Zunyi Medical University (Guizhou, China) in December 2017, due to recurrence of abdominal liposarcoma after 19 months of presenting for operation. This time, the patient presented with abdominal distension and abdominal pain with intermittent blunt pain in the right side for ten days, accompanied by lower extremity edema and right lumbosacral pain. The physical examination indicated a 12×10 cm oval mass with a clear boundary and soft-medium texture in the right abdomen without tenderness or rebound tenderness. The laboratory examinations, including routine blood and urine tests, gave results that were within the reference ranges and therefore normal. Computed tomography (CT; Figure 1A) demonstrated a giant mass containing fat density in the right abdomen, pressing into the right kidney and renal capsule; therefore, it was decided surgery was necessary.

Figure 1.

Figure 1

Abdominal computed tomography scan of the patient (CT). A: CT demonstrated a giant mass containing fat density in the right abdomen, pressing into the right kidney and renal capsule in the first relapse; B: CT showed the right liver was compressed by a large mass with mixed density at eight months after first relapse.

During surgery, it was determined that the multiple masses originated from the right abdomen fatty tissue adjacent to the kidney, inferior vena cava, and right liver. These masses had a complete capsule. The patient received complete resection of the liposarcoma and partial resection of inferior vena cava. The diameter of the masses werefrom 3 centimeters to 20 centimeters in size.

Macroscopic examination of the retroperitoneal multiple masses revealed nodular, soft masses that measured 3.5 to 20 cm in the largest dimension, with complete capsule. These masses were weighed at 2.5 kg. The cut surface was soft, yellow, dark-red, with a focal gelatinous, solid portion, cystic degeneration and hemorrhage (Figure 2). Microscopic examination demonstrated three patterns: the first part had stellate or spindle cells arranged in the shape of herring bone in dedifferentiated liposarcoma (Figure 3A), the second showed “chicken-wire” like pattern on the myxoid stroma (Figure 3B), the third showed most of tumor consisting of mature fat cell-like cells with occasional multivacuolated lipoblasts in the well-differentiated liposarcoma (Figure 3C). Immunohistochemical staining was negative for S-100 and positive for CDK4 protein in part of the spindle cells (Figure 3D), but was positive for S-100 in part of the mature fat cell-like cells. Definitive diagnosis was mixed-type liposarcoma composed of well-differentiated, dedifferentiated and myxoid areas, each of the components accounting for one third. After follow-up of 8 months, the patient experienced multiple metastases in the liver and abdominal wall, upper digestive tract hemorrhage, and hemorrhagic shock. Computed tomography showed a recurrence of right retroperitoneal fat-derived malignant tumors involving the right lobe, right kidney, left lobe of liver and right anterior abdominal wall (Figure 1B). The hemoglobin content was 34 g/L. The patient was in the hospital, and he has received therapy of tumor arterial infusion chemoembolization. After therapy, the patient was discharged without any complications, and has been well. We plan to follow up the patient every 6 months after discharge.

Figure 2.

Figure 2

Macroscopic findings: (A) 7 tumor masses found in retroperitoneum; (B-D) Cut surface: these were gray-white section, cystic hemorrhage, gray-yellow section respectively.

Figure 3.

Figure 3

Histologic examination findings: (A) The spindle cells are arranged in the shape of a herring bone in dedifferentiated liposarcoma (×200). (B) The morphologic hallmark of myxoid liposarcoma is the presence of a thin-walled, capillary size vascular network, organized in a distinctive plexiform pattern (×100); (C) Most of tumor consists of mature fat cell-like cells and a few atypical spindle cells or lipoblasts, with occasional multivacuolated lipoblasts in WD (×200). (D) Tumor cells showing diffuse nuclear immunoreactivity for CDK4 in DL (×100).

Discussion

Liposarcoma occurs most in the deep soft tissues of the extremities, trunk, and retroperitoneum. The most commonly diagnosed histologic types of liposarcoma are WDL and myxoid type. In addition, some liposarcomas are composed of two or more histologic types and the then classified as mixed-type liposarcoma. Mixed type liposarcomas are exceedingly rare. Only 5% of liposarcomas show an admixture of different histologic subtypes in the same tumor [6]. The present study describes a case of a mixed-type retroperitoneal liposarcoma with areas of WDL, MLPS and DLPS. In order to further dissect the clinicopathologic features of mixed liposarcoma, we present 23 mixed type liposarcomas with complete data in a review of the literature (Table 1).

Table 1.

Clinical data of 23 patients in the literature review

First author Gender/age Size (cm) Location Treatment Primary/recurrent Follow up
Liu [15] F (54) >15 Retroperitoneal CR Primary Don’t provide
Zoran [16] M (77) 30×15×15 Mesentery SE Primary Died (8 day after the surgery)
Yoon [17] M (41) 20×13×10 Ascending colon and retroperitoneum SE Primary Free of disease (24 m)
Jie [18] M (46) No Left palate SE Primary NED
Jie [18] F (28) No Left buccal region SE+PR Primary NED
Jennifer [19] M (47) 12.2×10.8×5 Scrotum SE Primary NED (10 mo)
Jennifer [19] F (61) 25×20×20 Retroperitoneum SE Primary NED (32 mo)
Jennifer [19] M (65) 15×12.5×7 Buttock SE+RT Primary NED (11 mo)
Jennifer [19] M (58) 21×15×12 Buttock SE Primary NED (24 mo)
Jennifer [19] F (78) 22×17×11 Retroperitoneum SE Primary NED (34 mo)
Jennifer [19] M (39) Fragmented Scrotum SE Primary NED (60 mo)
Jennifer [19] F (35) Fragmented Abdominal cavity SE Primary Dead of local disease at 29 mo
Jennifer [19] F (44) Large Retroperitoneum SE Recurrent Lung metastasis at mo; LR at 84 mo, alive with unresectable disease at last follow-up
Jennifer [19] M (84) 27×17.5×10 Retroperitoneum SE Primary Died of unrelated causes at 14 mo
Jennifer [19] M (56) 16.5×15×14 Retroperitoneum SE Primary NED (11 mo)
Jennifer [19] M (69) 35×29×20.5 Retroperitoneum SE Primary NED (12 mo)
Jennifer [19] F (73) 15×6.8×4 Retroperitoneum SE Primary NED (7 mo)
N.Tsoukalas [20] F (47) 15×11×10 Abdominal CR+postoperative RT Recurrent NED
Miguel J [21] M (68) 17.5×13×14 Posterior mediastinal SE+adjuvant chemotherapy Primary Died (3 mo later)
KUC [22] M (76) 9×5×5 Left upper arm SE Primary Don’t provide
Shashikant C.U [23] M (45) 6×5.5×5 Thigh SE+adjuvant chemotherapy Primary Alive with metastatic disease
Miura Y [24] M (71) Ned Right hemicolectomy SE Primary Alive with 52 months
The present case F (64) 64 Retroperitoneum SE Recurrent Two relapses, liver metastasis, alive with unresectable disease at last follow-up

In our review, 23 cases of mixed liposarcoma, 12 were located in retroperitoneum or abdominal cavity (41%), and the remaining 11 cases were located in other sites, which includes mesentery, ascending colon, left palate, left buccal region, thigh, subcutaneous, left palate, scrotum. Ages were 28-84 years of age, the mean age of the patients was 57 years, and the ratio between the genders was 9:14 (F:M). In liposarcoma, the most important prognostic factor is anatomic location, which is also the main predictor of relapse. Liposarcoma is much more aggressive when localized in the retroperitoneum. In our data, the cases located in mesentery, abdominal cavity, retroperitoneum, and posterior mediastinal suffered metastases and dead. We presented two recurrent cases located in the retroperitoneum and abdomen in the review.

In the first case reported by Wood and Morgenstern [7], tumor recurrence developed 3 years after surgery for myxoid colon liposarcoma. Some factors have been accepted as indicators of poor prognosis: age >45 years, presence of round cells, necrotic areas within the mass [8], and dissemination of the disease [9]. Our patient is 63 years old female, who after complete mass removal had a first recurrence 19 months after complete primary surgical resection. However, the patient had the second recurrence after one year. In the literature reviews of presentations, all patients were treated with complete surgical resection; however, two cases died of local disease at 29 months and 33 months, 2 cases died of unrelated causes at 8 days and 14 months, and 2 cases had lung metastasis at 60 months and 15 months. The case we reported had multiple liver and abdominal wall metastases at 8 months. These data suggest that mixed liposarcoma is a highly malignant tumor, and despite the complete removal of the mass, prognosis is guarded.

CT scan and magnetic resonance imaging are the best preoperative investigations for evaluation. The histopathologic diversity of a mixed liposarcoma may cause misdiagnosis in cytology and small biopsy. The final diagnosis of liposarcoma is dependent on the pathologic and immunohistochemical analyses, and some ambiguous cases require molecular biological detection. In our case, the patient suffered upper digestive tract hemorrhage owing to multiple metastases in the liver and abdominal wall. The CT scan demonstrated a giant mass containing fat density. Microscopically, the grey-white region was dedifferentiated liposarcoma, the grey-yellow region was well-differentiated liposarcoma, and the gelatinous region was myxoid liposarcoma. Pathologic sampling from different parts are necessary to avoid misdiagnosis.

A treatment protocol has not been established because of the small number of reported cases. Surgical resection is still the main method of treatment of retroperitoneal liposarcoma; complete resection to the naked eye is the goal of surgical resection clean, encroaching upon the viscera of multi-visceral resection. The effects of chemotherapy for liposarcoma are unknown [10], but radiotherapy has been shown to affect survival rates [11]. The patient was discussed with an oncologist and no adjuvant therapy was recommended but it was suggested that regular clinical follow-up every 6 months is needed. Prognosis of patients with mixed-type liposarcoma is based on the most aggressive type found in the tumor, which, in our case, was dedifferentiated liposarcoma.

However, mixed-type liposarcoma poses conceptual problems and clinical problems when stratifying patients for treatment. Jeung [12] demonstrated multiple genes are differentially expressed in mixed-type liposarcoma and suggests that these genes are associated with differences in the morphological characteristics and pathogenesis of mixed type liposarcoma. Morphologic heterogeneity as seen in mixed-type liposarcomas is then very likely explained by different levels of maturation within a single developmental pathway from an undifferentiated stem cell [12]. The latest literature shows that the mixed-type liposarcomas are thought mostly to be unusual examples of dedifferentiated liposarcoma, based on currently available immunohistochemical and molecular studies [13]. Therefore, mixed-type liposarcomas should not be regarded as collision tumors, but as an extreme variant of the morphologic spectrum within a single biological entity, explaining the biological contradiction of mixed-type liposarcoma [12]. However, in our presentation, the case contained a component of myxoid liposarcoma and dedifferentiated liposarcoma. One paper reported that there are different molecular changes between myxoid liposarcoma and well differentiated liposarcoma or dedifferentiated liposarcoma in mixed type liposarcomas, which should not be explained as being a collision tumor [14]. Jeung [12] demonstrated multiple genes are differentially expressed in mixed-type liposarcoma and suggests that these genes are associated with the differences in the morphologic characteristics and pathogenesis of mixed type liposarcoma. We speculate that mixed-type liposarcoma may show a worse prognosis, but there are no more data to support this prediction. More in-depth studies should be carried out to better understand this type of tumor.

Acknowledgements

This work was supported by Grant of Scientific and Technological Cooperation in Guizhou Province: Qian Ke he LH [2015] 7556.

Disclosure of conflict of interest

None.

References

  • 1.Fletcher CDM, Fletcher CD. Diagnostic Histopathology of Tumors. New York: Churchill Livingstone Elsevier; 2007. [Google Scholar]
  • 2.Fletcher CD UK, Meriens F. Editor world health organization classification of tumours: pathology and genetics of soft tissue and bone. Lyon: IARC Press; 2002. [Google Scholar]
  • 3.Mentzel T, Fletcher C. Dedifferentiated myxoid liposarcoma: a clinicopathological study suggesting a closer relationship between myxoid and well-differentiated liposarcoma. Histopathology. 1997;30:457–463. doi: 10.1046/j.1365-2559.1997.5510791.x. [DOI] [PubMed] [Google Scholar]
  • 4.Russell WO, Cohen J, Enzinger F, Hajdu SI, Heise H, Martin RG, Meissner W, Miller WT, Schmitz RL, Suit HD. A clinical and pathological staging system for soft tissue sarcomas. Cancer. 1977;40:1562–1570. doi: 10.1002/1097-0142(197710)40:4<1562::aid-cncr2820400428>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  • 5.Bradley J, Caplan R. Giant retroperitoneal sarcoma: a case report and review of the management of retroperitoneal sarcomas. Am Surg. 2002;68:52–56. [PubMed] [Google Scholar]
  • 6.Fabre-Guillevin E, Coindre J, Somerhausen NS, Bonichon F, Stoeckle E, Bui N. Retroperitoneal liposarcomas: follow-up analysis of dedifferentiation after clinicopathologic reexamination of 86 liposarcomas and malignant fibrous histiocytomas. Cancer. 2006;106:2725–2733. doi: 10.1002/cncr.21933. [DOI] [PubMed] [Google Scholar]
  • 7.Wood D, Morgenstern L. Liposarcoma of the ileocecal valve: a case report. Mt Sinai J Med. 1989;56:62–64. [PubMed] [Google Scholar]
  • 8.Enzinger FM, Weiss SH, Chandrasekhar B. Soft Tissue Tumors. 3rd edition. St Louis, MO: Mosby, Inc; 1995. [Google Scholar]
  • 9.D’Annibale M, Cosimelli M, Covello R, Stasi E. Liposarcoma of the colon presenting as an endoluminal mass. World J Surg Oncol. 2009;7:78. doi: 10.1186/1477-7819-7-78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Jones RL, Fisher C, Al-Muderis O, Judson IR. Differential sensitivity of liposarcoma subtypes to chemotherapy. Eur J Cancer. 2005;41:2853–2860. doi: 10.1016/j.ejca.2005.07.023. [DOI] [PubMed] [Google Scholar]
  • 11.Strander H, Turesson I, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in soft tissue sarcomas. Acta Oncol. 2003;42:516–531. doi: 10.1080/02841860310014732. [DOI] [PubMed] [Google Scholar]
  • 12.de Vreeze RS, de Jong D, Koops W, Nederlof PM, Ariaens A, Haas RL, van Coevorden F. Oncogenesis and classification of mixed-type liposarcoma: a radiological, histopathological and molecular biological analysis. Int J Cancer. 2011;128:778–786. doi: 10.1002/ijc.25390. [DOI] [PubMed] [Google Scholar]
  • 13.Jo VY, Fletcher CD. WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition. Pathology. 2014;46:95–104. doi: 10.1097/PAT.0000000000000050. [DOI] [PubMed] [Google Scholar]
  • 14.Mentzel T, Palmedo G, Hantschke M, Woziwodzki J, Beck C. Mixed-type liposarcoma: clinicopathological, immunohistochemical, and molecular analysis of a case arising in deep soft tissues of the lower extremity. Virchows Arch. 2008;453:197–201. doi: 10.1007/s00428-008-0624-7. [DOI] [PubMed] [Google Scholar]
  • 15.Zhang WD, Liu DR, Que RS, Zhou CB, Zhan CN, Zhao JG, Chen LI. Management of retroperitoneal liposarcoma: a case report and review of the literatur. Oncol Lett. 2015;10:405–409. doi: 10.3892/ol.2015.3193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Jukić Z, Brcić I, Zovak M, Vucić M, Mijić A, Kruslin B. Giant mixed-type liposarcoma of the mesentery: case report. Acta Clinica Croatica. 2012;51:97–101. [PubMed] [Google Scholar]
  • 17.Choi YY, Kim YJ, Jin SY. Primary liposarcoma of the ascending colon: a rare case of mixed type presenting as hemoperitoneum combined with other type of retroperitoneal liposarcoma. BMC Cancer. 2010;10:239. doi: 10.1186/1471-2407-10-239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Cheng J, Yu H, Wang L, Wang X, Shen G. Primary oral and maxillofacial liposarcoma: a clinicopathological and immunohistochemical study of eleven cases. Arch Med Sci. 2012;8:316–23. doi: 10.5114/aoms.2012.28560. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Boland JM, Weiss SW, Oliveira AM, Erickson-Johnson ML, Folpe AL. Liposarcomas with mixed well-differentiated and pleomorphic features: a clinicopathologic study of 12 cases. Am J Surg Pathol. 2010;34:837–43. doi: 10.1097/PAS.0b013e3181dbf2f7. [DOI] [PubMed] [Google Scholar]
  • 20.Tsoukalas N, Tolia M, Lypas G, Panopoulos C, Barbounis V, Koumakis G, Efremidis A. Complete remission of a reccurrent mesenteric liposarcoma with rare histological features following the administration of trabectedin. Oncol Lett. 2014;7:47–49. doi: 10.3892/ol.2013.1646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Arrarás-Martínez MJ, Rieger-Reyes C, Panadero-Paz C, Landa-Oviedo HS, García-Tirado J. Giant primary mediastinal liposarcoma: a rare cause of atrial flutter. Asian Cardiovasc Thorac Ann. 2015;23:1121–4. doi: 10.1177/0218492315589201. [DOI] [PubMed] [Google Scholar]
  • 22.Kim JI, Choi KU, Lee IS, Moon TY, Lee CH, Kim HW, Kim JY, Park DY, Sol MY. Gene expression in mixed type liposarcoma. Pathology. 2006;38:114–9. doi: 10.1080/00313020600557078. [DOI] [PubMed] [Google Scholar]
  • 23.Patne SC, Kumar M, Vishwanath A, Pandey M. Primary subcutaneous mixed-type liposarcoma of the thigh showing three simultaneous dedifferentiations: report of an unusual case. Indian J Pathol Microbiol. 2013;56:419–21. doi: 10.4103/0377-4929.125358. [DOI] [PubMed] [Google Scholar]
  • 24.Miura Y, Sakata J, Ando T, Soma D, Yuza K, Hirose Y, Ishikawa H, Miura K, Takizawa K, Kobayashi T, Ichikawa H, Nagahashi M, Shimada Y, Kameyama H, Wakai T. Mixed type liposarcoma with intra-abdominal bleeding-report of a case. Gan To Kagaku Ryoho. 2017;44:1155–1157. [PubMed] [Google Scholar]

Articles from International Journal of Clinical and Experimental Pathology are provided here courtesy of e-Century Publishing Corporation

RESOURCES